Live Breaking News & Updates on Thoracic Oncology Research Program

Stay updated with breaking news from Thoracic oncology research program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neoadjuvant nivolumab plus chemotherapy extends EFS in non-small cell lung cancer

Neoadjuvant nivolumab plus chemotherapy significantly improved EFS in stage IB to stage IIIA resectable non-small cell lung cancer, according to research presented at American Association for Cancer Research Annual Meeting. Results of the randomized phase 3 CheckMate 816 trial, published simultaneously in The New England Journal of Medicine, also showed no new adverse events associated with the ....

United States , Patrickm Forde , Ryan Lawrence , Nicolas Girard , Eli Lilly , Jennifer Southall , Thoracic Oncology Research Program , Versailles Saint Quentin University , American Association For Cancer Research Annual Meeting , Curie Montsouris Thorax Institute , Bristol Myers Squibb , American Association , Cancer Research Annual Meeting , Takeda Oncology , Cancer Research Annual , New England Journal , Bloomberg Kimmel Institute , Johns Hopkins University ,